First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen)

Giovanni Schinzari, Ernesto Rossi, Giuseppina Mambella, Antonia Strippoli, Rodolfo Cangiano, Massimiliano Mutignani, Michele Basso, Alessandra Cassano, Carlo Barone

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen)'. Together they form a unique fingerprint.

Medicine & Life Sciences